c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
MAIA Biotechnology Expands Pivotal Phase 3 THIO-104 Non-Small Cell Lung Cancer Trial into Spain and Portugal
GlobeNewswire Inc. | Sep 23, 2026 9:17 AM EDT
THIO-104 advances toward key 2027 interim survival analysis
Read original article